Immucell (ICCC) Interest & Investment Income (2009 - 2026)
Immucell's Interest & Investment Income was $69,960 in Q3 2026, up 68.7% from $41,468 a year earlier and up 7.1% from the prior quarter.
Immucell (ICCC) Interest & Investment Income (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Immucell's Interest & Investment Income was $211,329 through Sep 30, 2026, up 29.4% year-over-year; for FY2025, it came in at $158,709, up 104.3% from FY2024.
- Interest & Investment Income shows a three-year compound annual growth rate of 1.2% (FY2022 to FY2025).
- In earlier years, Interest & Investment Income was $77,702 in FY2024 (-19.5%), $96,570 in FY2023 (-36.9%) and $153,100 in FY2022.
- The Q3 2026 figure marks the highest quarterly Interest & Investment Income in data going back to Q1 2009.
- Compared with a year earlier, Interest & Investment Income has increased for three straight quarters, with growth averaging 112.6% over the last seven quarters.
- The best year-over-year quarter for Interest & Investment Income over five years was Q1 2025 (growth of 293.3%); the worst was Q1 2024 (a decline of 76.6%).
- Per Business Quant data, ICCC's Interest & Investment Income in the three quarters before Q3 2026 was $65,343 (Q2 2026), $44,367 (Q1 2026) and $31,659 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | - |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | - |
| 10 | Immucell | 102.43 Mn | 75.03 Mn | 3.56 Mn | 69,960.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 69,960.00 |
| Jun 30, 2026 | 65,343.00 |
| Mar 31, 2026 | 44,367.00 |
| Dec 31, 2025 | 31,659.00 |
| Sep 30, 2025 | 41,468.00 |
| Jun 30, 2025 | 48,113.00 |
| Mar 31, 2025 | 37,469.00 |
| Dec 31, 2024 | 36,226.00 |
| Sep 30, 2024 | 18,685.00 |
| Jun 30, 2024 | 13,264.00 |
| Mar 31, 2024 | 9,527.00 |
| Jun 30, 2023 | 14,806.00 |
| Mar 31, 2023 | 40,631.00 |
| Dec 31, 2019 | 27,150.00 |
| Sep 30, 2019 | 41,719.00 |
| Jun 30, 2019 | 47,099.00 |
| Mar 31, 2019 | 2,315.00 |
| Dec 31, 2018 | 4,031.00 |
| Sep 30, 2018 | 3,237.00 |
| Jun 30, 2018 | 3,209.00 |
Immucell Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ICCC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();